AMALGAMATED BANK - ANTARES PHARMA INC ownership

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$111,000
-47.1%
27,177
-53.9%
0.00%0.0%
Q4 2021$210,000
+92.7%
58,940
+97.1%
0.00%0.0%
Q3 2021$109,000
-20.4%
29,904
-5.1%
0.00%0.0%
Q2 2021$137,000
+30.5%
31,523
+23.5%
0.00%
-75.0%
Q1 2021$105,000
+2.9%
25,5340.0%0.00%0.0%
Q4 2020$102,000
+47.8%
25,534
+0.5%
0.00%
+33.3%
Q3 2020$69,000
-2.8%
25,414
-2.2%
0.00%0.0%
Q2 2020$71,000
+6.0%
25,978
-9.0%
0.00%
+50.0%
Q1 2020$67,000
-50.0%
28,552
+0.5%
0.00%0.0%
Q4 2019$134,000
+41.1%
28,4180.0%0.00%0.0%
Q3 2019$95,000
+1.1%
28,418
-0.8%
0.00%0.0%
Q2 2019$94,000
+38.2%
28,650
+27.2%
0.00%0.0%
Q1 2019$68,000
+15.3%
22,521
+3.5%
0.00%0.0%
Q4 2018$59,000
+1.7%
21,766
-2.4%
0.00%
+100.0%
Q2 2018$58,000
+38.1%
22,299
+17.2%
0.00%0.0%
Q1 2018$42,000
+10.5%
19,020
-1.0%
0.00%0.0%
Q4 2017$38,000
-35.6%
19,203
+4.8%
0.00%
-50.0%
Q3 2017$59,000
+5.4%
18,326
+5.2%
0.00%0.0%
Q2 2017$56,000
+300.0%
17,428
+6.8%
0.00%
+100.0%
Q1 2016$14,000
-22.2%
16,323
+9.7%
0.00%
-50.0%
Q4 2015$18,000
-33.3%
14,879
-7.9%
0.00%
-33.3%
Q3 2015$27,000
-18.2%
16,157
+0.9%
0.00%0.0%
Q2 2015$33,000
+3.1%
16,010
+34.9%
0.00%
-25.0%
Q1 2015$32,000
+10.3%
11,871
+4.1%
0.00%
-20.0%
Q4 2014$29,000
+38.1%
11,405
+0.2%
0.01%
+66.7%
Q3 2014$21,000
-30.0%
11,386
-0.0%
0.00%
-40.0%
Q2 2014$30,000
-26.8%
11,390
-2.2%
0.01%
-28.6%
Q1 2014$41,000
-21.2%
11,649
-0.5%
0.01%
-22.2%
Q4 2013$52,00011,7030.01%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 3,096,355$8,422,0005.18%
JW Asset Management, LLC 1,920,524$5,224,0003.85%
Healthcare Value Capital, LLC 250,000$680,0002.64%
ARMISTICE CAPITAL, LLC 10,300,000$28,016,0002.12%
Broadfin Capital, LLC 3,444,147$9,368,0001.23%
PERKINS CAPITAL MANAGEMENT INC 409,000$1,112,0000.86%
MYCIO WEALTH PARTNERS, LLC 1,896,500$5,158,0000.48%
ESSEX INVESTMENT MANAGEMENT CO LLC 1,012,600$2,754,0000.22%
FALCON POINT CAPITAL, LLC 130,200$354,0000.21%
Brown Advisory Securities, LLC 275,000$781,0000.15%
View complete list of ANTARES PHARMA INC shareholders